Sep. 15, 2021—Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.
Sep. 9, 2021—Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.
Sep. 2, 2021—Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.
Aug. 12, 2021—The Structural Heart and Valve Center at Vanderbilt Heart and Vascular Institute (VHVI) has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves, a continuation of a decade of research that is revolutionizing the treatment of these conditions.
Jun. 9, 2021—The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.
Jan. 7, 2021—Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.
Dec. 10, 2020—Two Vanderbilt Heart and Vascular Institute researchers are receiving awards from the American Heart Association.
Apr. 21, 2016—The Division of Cardiovascular Medicine will host the Vanderbilt Cardiovascular Symposium 2016 on May 4, highlighting ongoing vascular and heart-related basic and clinical research.
Feb. 11, 2016—When Rob Hood, M.D., began practicing cardiology 30 years ago he could not have imagined that fitness would one day be measured on a device worn around his wrist.
Apr. 9, 2015—When atherosclerosis develops in the coronary arteries over a period of time, complete blockage of that artery can result in chest pain, shortness of breath and decreased quality of life.